Bone marrow transplants are not typically used as a primary treatment for bone cancer (osteosarcoma or Ewing sarcoma). BMT primarily targets blood cancers (like leukemia and lymphoma) where the cancer originates in the bone marrow itself. Bone cancer, on the other hand, originates in the bone tissue.
The main treatments for bone cancer focus on localized destruction of the tumor, such as:
Surgery to remove the tumor, Chemotherapy, and Radiation therapy. Bone marrow transplants might be considered for bone cancer patients who have also developed leukemia or other blood cancers as a secondary complication of their treatment (like chemotherapy).
Here are some very specific and limited circumstances where they might be considered:
Myelodysplastic Syndromes (MDS): Some bone cancer treatments, particularly high doses of chemotherapy, can damage the bone marrow and lead to MDS. MDS is a group of disorders where the bone marrow doesn’t produce enough healthy blood cells. In these cases, a bone marrow transplant might be necessary to restore healthy blood cell production.
Leukemia Development: In extremely rare instances, patients with bone cancer may develop leukemia as a secondary complication of their treatment. If this occurs, a bone marrow transplant might be considered to treat the leukemia.
These situations are highly unusual. Bone marrow transplants for bone cancer are not standard practice and are only considered in very specific and often complex cases. The decision to pursue a bone marrow transplant is always made on an individual basis by a team of medical experts, weighing the potential benefits against the significant risks of the procedure.
For more information visit the official site:: https://www.edhacare.com/treatments/organ-transplant/bone-marrow
.
